← Back to Search

Multicomponent Lexical Retrieval Training (Multi-LRT) for Semantic Dementia

N/A
Waitlist Available
Led By Maya L Henry, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
* Scores of 10 or higher on the Mini-Mental State Examination
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-treatment (approximately 6-12 weeks after treatment onset)
Awards & highlights
No Placebo-Only Group

Summary

Primary progressive aphasia (PPA) is a progressive neurological disorder that causes a gradual decline in communication ability as a result of selective neurodegeneration of speech and language networks in the brain. PPA is a devastating condition affecting adults as young as in their 50's, depriving them of the ability to communicate and function in society. As a result of improved diagnostic precision, PPA is now identified with greater accuracy and frequency and, increasingly, patients and their families seek options for behavioral treatments to ameliorate the devastating effects on their communication, prolong speech language skills, and maximize quality of life. Speech-language treatment outcomes from our group and others are encouraging, confirming that behavioral intervention may lead to improvements in trained behaviors and, for some interventions, lasting and generalized benefit. Most speech-language interventions for individuals with PPA that have been explored in the literature are restitutive, or impairment-based in nature, and have not addressed the full range of severity and phenotypic variability in this population. The investigators will evaluate the utility of a novel, multicomponent intervention that incorporates elements of restitutive (e.g., word finding strategic training, script training), compensatory (e.g., multimodal communication, communication book), and care partner-focused treatment to meet the needs of individuals varying in clinical presentation and severity.

Eligible Conditions
  • Semantic Dementia
  • Semantic Memory Disorder
  • Primary Progressive Aphasia
  • Nonfluent Aphasia
  • Aphasia
  • Progressive Aphasia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in script production accuracy
Change in spoken naming of trained/untrained items
Goal Attainment Score
+1 more
Secondary study objectives
Change on Aphasia Impact Questionnaire
Change on Quick Aphasia Battery
Other study objectives
Post-treatment Communication Survey

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Multicomponent Video Implemented Script Training in Aphasia (Multi-VISTA)Experimental Treatment1 Intervention
Group II: Multicomponent Lexical Retrieval Training (Multi-LRT)Experimental Treatment1 Intervention
Group III: Multicomponent Communicaiton Partner Training (Multi-CPT)Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
373 Previous Clinical Trials
84,039 Total Patients Enrolled
1 Trials studying Semantic Dementia
60 Patients Enrolled for Semantic Dementia
Maya L Henry, PhDPrincipal InvestigatorUniversity of Texas - Austin
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Semantic Dementia
60 Patients Enrolled for Semantic Dementia
~6 spots leftby May 2025